We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Yerba Mate Tea Shown to Inhibit Colon Cancer

By LabMedica International staff writers
Posted on 01 Feb 2012
Print article
Scientists revealed that human colon cancer cells die when they are exposed to the bioactive compounds present in one cup of Yerba Mate (Ilex paraguariensis), which has long been consumed in South America for its medicinal qualities.

“The caffeine derivatives in mate tea not only induced death in human colon cancer cells, they also reduced important markers of inflammation,” said Dr. Elvira de Mejia, a University of Illinois (U of I; Urbana-Champaign, USA) associate professor of food chemistry and food toxicology. That is important because inflammation can trigger the steps of cancer progression, she said.

In the in vitro study, Dr. de Mejia and former graduate student Sirima Puangpraphant isolated, purified, and then treated human colon cancer cells with caffeoylquinic acid (CQA) derivatives from mate tea. As the scientists increased the CQA concentration, cancer cells died as a result of apoptosis. “Put simply, the cancer cell self-destructs because its DNA has been damaged,” she said.

The ability to induce apoptosis is a promising approach for therapeutic interventions in all types of cancer, reported Dr. de Mejia. She stated that they were able to identify the process that led to cell death. Specific CQA derivatives drastically decreased several markers of inflammation, including NF-kappa-B (nuclear factor kappa-light-chain-enhancer of activated B cells), which regulates many genes that affect the process through the production of key enzymes. Ultimately, cancer cells died with the induction of two specific enzymes, caspase-3 and caspase-8, according to Dr. de Mejia. “If we can reduce the activity of NF-kappa-B, the important marker that links inflammation and cancer, we’ll be better able to control the transformation of normal cells to cancer cells,” she added.

The study’s findings strongly suggest that the caffeine derivatives in mate tea have potential as anticancer agents and could also be helpful in other diseases associated with inflammation, according to Dr. de Mejia. However, because the colon and its microflora play a key role in the absorption and metabolism of caffeine-related compounds, the anti-inflammatory and anticancer effects of mate tea may be most beneficial in the colon. “We believe there’s ample evidence to support drinking mate tea for its bioactive benefits, especially if you have reason to be concerned about colon cancer. Mate tea bags are available in health food stores and are increasingly available in large supermarkets,” she added.

The scientists have already completed and will soon publish the results of a study that compares the development of colon cancer in lab rats that drank mate tea as their only source of water with a control group that drank only water.

The in vitro study’s findings were published November 2011 in the journal Molecular Nutrition & Food Research.

Related Links:

University of Illinois


Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Malondialdehyde HPLC Test
Malondialdehyde in Serum/Plasma – HPLC
New
POC Procalcitonin Test
B·R·A·H·M·S PCT-Q Rapid Test

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.